163 related articles for article (PubMed ID: 23933063)
1. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
2. Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression.
Jóźwicki W; Brożyna AA; Siekiera J
Int J Mol Sci; 2014 Sep; 15(9):16069-82. PubMed ID: 25216339
[TBL] [Abstract][Full Text] [Related]
3. Oct4 pseudogenes are transcribed in cancers.
Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
[TBL] [Abstract][Full Text] [Related]
4. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
Xu G; Yang L; Zhang W; Wei X
Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
[TBL] [Abstract][Full Text] [Related]
5. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines.
Poursani EM; Mohammad Soltani B; Mowla SJ
Cell J; 2016; 18(1):28-36. PubMed ID: 27054116
[TBL] [Abstract][Full Text] [Related]
7. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
8. Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells.
Jez M; Ambady S; Kashpur O; Grella A; Malcuit C; Vilner L; Rozman P; Dominko T
PLoS One; 2014; 9(2):e89546. PubMed ID: 24586860
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
10. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
[TBL] [Abstract][Full Text] [Related]
11. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
12. Novel spliced variants of OCT4, OCT4C and OCT4C1, with distinct expression patterns and functions in pluripotent and tumor cell lines.
Malakootian M; Mirzadeh Azad F; Naeli P; Pakzad M; Fouani Y; Taheri Bajgan E; Baharvand H; Mowla SJ
Eur J Cell Biol; 2017 Jun; 96(4):347-355. PubMed ID: 28476334
[TBL] [Abstract][Full Text] [Related]
13. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
14. An Overview on the Complexity of OCT4: at the Level of DNA, RNA and Protein.
Mehravar M; Ghaemimanesh F; Poursani EM
Stem Cell Rev Rep; 2021 Aug; 17(4):1121-1136. PubMed ID: 33389631
[TBL] [Abstract][Full Text] [Related]
15. Induced overexpression of OCT4A in human embryonic stem cells increases cloning efficiency.
Tsai SC; Chang DF; Hong CM; Xia P; Senadheera D; Trump L; Mishra S; Lutzko C
Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1108-18. PubMed ID: 24627557
[TBL] [Abstract][Full Text] [Related]
16. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
17. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
Mehravar M; Poursani EM
Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
[TBL] [Abstract][Full Text] [Related]
18. microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1.
Fujii T; Shimada K; Tatsumi Y; Hatakeyama K; Obayashi C; Fujimoto K; Konishi N
BMC Cancer; 2015 Oct; 15():818. PubMed ID: 26514209
[TBL] [Abstract][Full Text] [Related]
19. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S; Stephan M; Kögler G
Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
[TBL] [Abstract][Full Text] [Related]
20. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
